https://www.adventhealth.com/institute/adventhealth-research-institute/orthopedic-research/clinical-trials/optimal-dosing-low-dose-aspirin-chemoprophylaxis-venous-thromboembolism-following-total-joint
Our primary objective is to evaluate the efficacy of two different regimens, 81mg aspirin daily vs 81mg aspirin BID, in providing prophylaxis against...
low dose aspirinvenous thromboembolismoptimaldosingchemoprophylaxis